Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06919913

The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
152 (estimated)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether probiotics in addition to standard of care (SOC) can improve immunological markers following treatment for prosthetic joint infection (PJI). The study aims to determine whether probiotics in addition to SOC decrease immunological markers following treatment for PJI, improve medical and surgical complications and mortality in patients with PJI, and lead to improved gastrointestinal (GI)-specific patient reported outcomes measures (PROMs) in patients with PJI.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCulturelle Digestive Daily Probiotic CapsuleEach capsule contains 10 billion colony-forming units (CFU) of Lactobacillus rhamnosus GG. Subjects will self-administer 1 oral capsule daily for 6 weeks post operatively.

Timeline

Start date
2025-07-12
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2025-04-09
Last updated
2026-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06919913. Inclusion in this directory is not an endorsement.